Taken together, the above studies suggest that EZH2 and DNMT play a role in the formation of immunosuppressive TME, with complex interactions between cancer cells and non-cancerous cells in the TME that induce epigenetic changes in each other. This evidence concerns the gene EZH2 and cancer.